XBRUBTLS
Market cap122mUSD
Dec 20, Last price
3.13EUR
1D
0.00%
1Q
0.97%
IPO
-59.24%
Name
Biotalys NV
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-21m
L-9.77%
CFO
-18m
L-9.00%
Earnings
Apr 23, 2025
Profile
Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | 23,559 | 25,480 | 20,074 | |||
Unusual Expense (Income) | ||||||
NOPBT | (23,559) | (25,480) | (20,074) | |||
NOPBT Margin | ||||||
Operating Taxes | 56 | (38) | 16 | |||
Tax Rate | ||||||
NOPAT | (23,615) | (25,442) | (20,090) | |||
Net income | (20,510) -9.77% | (22,731) 34.27% | (16,929) 57.48% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 6,962 | 236 | 49,675 | |||
BB yield | -4.72% | -0.11% | -45.22% | |||
| Debt | ||||||
Debt current | 1,163 | 1,186 | ||||
Long-term debt | 3,185 | 5,338 | 6,037 | |||
Deferred revenue | ||||||
Other long-term liabilities | 5,467 | 105 | 113 | |||
Net debt | (18,385) | (27,595) | (48,884) | |||
| Cash flow | ||||||
Cash from operating activities | (18,283) | (20,091) | (16,754) | |||
CAPEX | (341) | (707) | (1,332) | |||
Cash from investing activities | 233 | (684) | (1,324) | |||
Cash from financing activities | 5,530 | (1,242) | 51,083 | |||
FCF | (23,046) | (25,154) | (20,418) | |||
| Balance | ||||||
Cash | 21,570 | 34,096 | 56,107 | |||
Long term investments | ||||||
Excess cash | 21,570 | 34,096 | 56,107 | |||
Stockholders' equity | 10,081 | 24,887 | 26,114 | |||
Invested Capital | 20,955 | 19,833 | 40,137 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 31,587 | 30,898 | 15,427 | |||
Price | 4.67 -31.32% | 6.80 -4.49% | 7.12 | |||
Market cap | 147,512 -29.79% | 210,108 91.28% | 109,842 | |||
EV | 129,127 | 182,513 | 60,958 | |||
EBITDA | (21,775) | (23,905) | (18,604) | |||
EV/EBITDA | ||||||
Interest | 247 | 246 | ||||
Interest/NOPBT | ||||||